MAP PHARMACEUTICALS, INC. Depreciation and Amortization
MAP PHARMACEUTICALS, INC. reported Depreciation and Amortization of $8.71 million for the 111-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2012-11-06
- MAP PHARMACEUTICALS, INC. depreciation, depletion and amortization for the quarter ending 2012-09-30 was $459.00K, a 9.03% increase year-over-year.
- MAP PHARMACEUTICALS, INC. depreciation, depletion and amortization for the quarter ending 2012-06-30 was $465.00K, a 42.20% increase year-over-year.
- MAP PHARMACEUTICALS, INC. depreciation, depletion and amortization for the quarter ending 2012-03-31 was $454.00K, a 60.99% increase year-over-year.
- MAP PHARMACEUTICALS, INC. depreciation, depletion and amortization for the quarter ending 2011-12-31 was $420.00K, a 44.33% increase year-over-year.
- MAP PHARMACEUTICALS, INC. depreciation, depletion and amortization for fiscal 2011 was $1.45M, a 18.66% increase from fiscal 2010.
- MAP PHARMACEUTICALS, INC. depreciation, depletion and amortization for fiscal 2010 was $1.22M, a 17.21% decline from fiscal 2009.
- MAP PHARMACEUTICALS, INC. depreciation, depletion and amortization for fiscal 2009 was $1.48M.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month | Depreciation, Depletion and Amortization 96 month | Depreciation, Depletion and Amortization 99 month | Depreciation, Depletion and Amortization 102 month | Depreciation, Depletion and Amortization 105 month | Depreciation, Depletion and Amortization 108 month | Depreciation, Depletion and Amortization 111 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | $459.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $924.00K derived: sum of 2 quarters · filed 2012-11-06 | $1.38M 10-Q · filed 2012-11-06 | $1.80M derived: sum of 4 quarters · filed 2012-11-06 | $8.71M 10-Q · filed 2012-11-06 | |||||
| 2012-06-30 | $465.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | $919.00K 10-Q · filed 2012-07-27 | $1.34M derived: sum of 3 quarters · filed 2012-07-27 | $1.76M derived: sum of 4 quarters · filed 2012-11-06 | $8.25M 10-Q · filed 2012-07-27 | |||||
| 2012-03-31 | $454.00K 10-Q · filed 2012-05-08 | $874.00K derived: sum of 2 quarters · filed 2012-05-08 | $1.29M derived: sum of 3 quarters · filed 2012-11-06 | $1.62M derived: sum of 4 quarters · filed 2012-11-06 | $7.78M 10-Q · filed 2012-05-08 | |||||
| 2011-12-31 | $420.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $841.00K derived: sum of 2 quarters · filed 2012-11-06 | $1.17M derived: sum of 3 quarters · filed 2012-11-06 | $1.45M 10-K · filed 2012-03-30 | $7.33M 10-K · filed 2012-03-30 | |||||
| 2011-09-30 | $421.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $748.00K derived: sum of 2 quarters · filed 2012-11-06 | $1.03M 10-Q · filed 2012-11-06 | $1.32M derived: sum of 4 quarters · filed 2012-11-06 | $6.91M 10-Q/A · filed 2012-03-30 | |||||
| 2011-06-30 | $327.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | $609.00K 10-Q · filed 2012-07-27 | $900.00K derived: sum of 3 quarters · filed 2012-07-27 | $1.19M derived: sum of 4 quarters · filed 2012-07-27 | $6.49M 10-Q/A · filed 2012-03-30 | |||||
| 2011-03-31 | $282.00K 10-Q · filed 2012-05-08 | $573.00K derived: sum of 2 quarters · filed 2012-05-08 | $863.00K derived: sum of 3 quarters · filed 2012-05-08 | |||||||
| 2010-12-31 | $291.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-30 | $581.00K derived: sum of 2 quarters · filed 2012-03-30 | $1.22M 10-K · filed 2012-03-30 | |||||||
| 2010-09-30 | $290.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-30 | $931.00K 10-Q/A · filed 2012-03-30 | ||||||||
| 2010-06-30 | $641.00K 10-Q/A · filed 2012-03-30 | |||||||||
| 2009-12-31 | $1.48M 10-K · filed 2012-03-30 |